Business Wire

Traceable Releases 2025 State of API Security Report: API Breaches Persist as Fraud, Bot Attacks, and Generative AI Increase Risks

30.10.2024 14:25:00 EET | Business Wire | Press release

Share

Traceable AI, the industry's leading API security company, today released its second annual research report—the 2025 Global State of API Security. The findings demonstrate that organizations are failing to protect their APIs despite persistent breaches and increased awareness of security risks. This comprehensive study, incorporating insights from over 1,500 IT and cybersecurity experts across the US, UK, and EMEA, reveals fundamental weaknesses in API security strategies and tracks how these issues have shifted since our inaugural report.

Key findings examine the most pressing API security issues organizations face today: increasing bot attacks and fraud, risks from third-party APIs, and the new security implications of generative AI applications.

Download the full report for in-depth analysis.

Key Findings Include:

  1. API-Related Data Breaches Continue to Wreak Havoc: 57% of organizations suffered an API-related data breach in the past two years, with a staggering 73% of these experiencing three or more incidents. Even more concerning, 41% endured five or more breaches, revealing a systemic failure in API defenses and a clear need for investment in purpose-built API security solutions.
  2. Traditional Security Solutions Fail to Deliver API Protection: Despite deploying an array of security tools—from legacy WAFs to CDNs and Gateways—only 19% of organizations rate their defenses as highly effective. Moreover, 53% admit that traditional solutions like WAFs and WAAPs are ineffective at identifying or preventing fraud at the API layer.
  3. Generative AI Applications Create New Risks: 65% of organizations state that generative AI applications pose a serious to extreme risk to APIs. 60% state that the additional API integrations required for generative AI applications expand their organization’s attack surface; the same percentage cite concerns about sensitive data exposure and unauthorized access.
  4. Bot Attacks and Fraud are Rampant: 53% of organizations have experienced one or more bot attacks involving their APIs, and 44% say that bot mitigation is a top challenge. Fraud is equally concerning, emerging as the second most prevalent cause of API-related data breaches among survey respondents.
  5. Third-Party APIs Are a Hidden Danger: Organizations now use an average of 131 third-party APIs, up slightly from last year's 127. Yet, only 16% have a “high ability” to mitigate these external risks, leaving a vast attack surface greatly exposed.

"API breaches are rampant, and the industry is in denial,” said Richard Bird, Chief Security Officer of Traceable. “Organizations keep deploying the same solutions—Web Application Firewalls, API gateways, and lifecycle tools—yet only a small percentage report any real success. This cognitive dissonance is a ticking time bomb. The truth is, these traditional defenses are failing, and the more companies rely on them, the more they expose themselves to devastating attacks. We’re also seeing a surge in bot attacks, increasing instances of API fraud, and new vulnerabilities emerging from the rapid adoption of generative AI applications. Companies must confront the uncomfortable truth: their current strategies are inadequate. Without a fundamental shift in how they secure APIs, breaches and their consequences will continue to escalate.”

Traceable conducts this annual research to provide organizations with an objective assessment of API security risks and trends. By tracking these patterns and emerging threats, we aim to offer security leaders the knowledge needed to make informed decisions and prioritize the most important security challenges. Our commitment is to ensure that as APIs continue to be central to business operations, organizations have the insights they need to protect their critical assets.

Download the full 2025 State of API Security report today.

About Traceable

Traceable’s intelligent and context-aware solution powers complete API security, API discovery and posture management, API security testing, attack detection and threat hunting, and attack protection anywhere your APIs live. Traceable enables organizations to minimize risk and maximize the value that APIs bring their customers. To learn more about how API security can help your business, book a demo with a security expert.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241030645718/en/

Contacts

Ryan Romana
Touchdown PR
traceable@touchdownpr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software27.6.2026 00:28:00 EEST | Press release

VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and anchored to frameworks designed for a different threat landscape. The problem: threat modeling matters more than ever—and most tools are stuck in 2005 For two decades, application threat modeling has leaned heavily on

Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 23:30:00 EEST | Press release

Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven

Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release

Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro

Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o

Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye